Immunic is trading at $7.00, up 5.11%, in a move that appears consistent with biotech-sector strength.

  • Biotech ETF XBI was up 2.20% in regular trading, providing supportive sector context.
  • No new major company announcement was listed for October 15; the latest releases were an October 13 inducement-grant notice and an October 7 conference-data announcement.
  • No clear company-specific catalyst was identified.